Skip to content

FYSIOMED

Active
Public limited companyfounded 1978active for 48 yearsDoornstraat 87-89, 2650 Edegem, BelgiumKBO/BCE: BE 0418.186.004
Summary

FYSIOMED has been active since 1978 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €118,601 and a net result of -€88,370. Equity is shrinking by about 18% per year across the filed financial years. Its solvency ranks better than 19% of 6,071 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
#5 oldest company in Edegem, Wholesale and retail trade sector1 site
Size
€663,931total assets 2025
Staff
1.3 FTE
Equity
€118,601
Loss
-€88,370
Financial health
66 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
0.8%
Structure
Accounts 35 days early0 of 9 deeds read
Why 66raises riskLoss of €88,370 (financial year 2025)Equity €118,601 (17.9% of total assets)Sector: Wholesale trade (NACE 46)lowers riskSize: 1.3 FTE, total assets €663,931Show the evidence

Checked score

Score 2025
66 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 19% of its sector peers (NACE 46, micro)
Financial strength · tick = 2024
Weak
Solvency 43-12
equity 17.9% of total assets
Liquidity 22-5
short-term debt 71.2% · cash 8.5%
Profitability 2-32
return on assets -13.3%
Bankruptcy probability, 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%

About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,867 companies, NACE 46, micro)
Last 24 months 11-2024: 0.6% 12-2024: 0.6%● unchanged vs 11-2024 01-2025: 0.6%● unchanged vs 12-2024 02-2025: 0.6%● unchanged vs 01-2025 03-2025: 0.6%● unchanged vs 02-2025 04-2025: 0.7%▲ +0.1 percentage points vs 03-2025 05-2025: 0.7%● unchanged vs 04-2025 06-2025: 0.7%● unchanged vs 05-2025 07-2025: 0.9%▲ +0.2 percentage points vs 06-2025 08-2025: 0.3%▼ -0.6 percentage points vs 07-2025lowest value 09-2025: 0.3%● unchanged vs 08-2025lowest value 10-2025: 0.3%● unchanged vs 09-2025lowest value 11-2025: 0.3%● unchanged vs 10-2025lowest value 12-2025: 0.3%● unchanged vs 11-2025lowest value 01-2026: 0.3%● unchanged vs 12-2025lowest value 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.7%▲ +0.4 percentage points vs 07-2026 09-2026: 0.9%▲ +0.2 percentage points vs 08-2026highest value 10-2026: 0.8%▼ -0.1 percentage points vs 09-2026
Credit of up to €7,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.95, compared with 1.29 in 2024; short-term debt: 71.2% and cash: 8.5% of total assets), and 82.1% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro): better than 29% on solvency, 21% on liquidity, 13% on profitability and 11% on growth.

The bankruptcy probability was computed on 08-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
−lowers risk+raises risk○neutral
raises risk · Loss of €88,370 (financial year 2025)
NBB · annual accounts
raises risk · Equity €118,601 (17.9% of total assets)
NBB · annual accounts
lowers risk · Size: 1.3 FTE, total assets €663,931
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
raises risk · Sector: Wholesale trade (NACE 46)
KBO
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 19% of 6071 sector peers (2025).
NBB · sector comparison
Position among 6071 sector peers
Solvency
better than 19%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-06-2026, 35 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
35 days early
2024
15 days early
2023
36 days early
2022
38 days early
2021
33 days early
2020
29 days early
2019
32 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 31 days before the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
09-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · full…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Back to profitnet €7,549

Key points

  • Caution: From profit to loss in 2025after €7,549 in 2024 -€88,370 View
  • Caution: Among the weakest 13% on equitysector median €1.6m · 6,010 companies €118,601 View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Active since 1978founded 08-03-1978 48 years View

By topic

Financials

Financial year
2025
Total assets
€663,931
Loss
-€88,370
Solvency
17.9%
Total assets▼ 3.5%
Net result
20182025
Go to Financials

Timeline

Events
53
Since
1979
Next accounts
by 31-07-2027
  1. 31-12-2024Equity above €200,000
  2. 25-06-2024Annual accounts filed
  3. 23-06-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
08-03-1978
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.